After stroke onset: higher levels of MPO-DNA and citH3 in AIS (p < 0.01), no significant variability between conventional treatment and Eda.B group.At day 3: significant decrease in MPO-DNA, citH3 in Eda B group (p< 0.01). Strong correlation between NETs and serum occludin levels. This evidence concerns the gene MPO and stroke disorder.